Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09DWA
|
|||
| Former ID |
DNC007796
|
|||
| Drug Name |
(10H-phenothiazin-10-yl)(o-tolyl)methanone
|
|||
| Synonyms |
CHEMBL397099; AC1MRTR1; (10H-phenothiazin-10-yl)(o-tolyl)methanone; Oprea1_791821; BDBM50219215
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H15NOS
|
|||
| Canonical SMILES |
CC1=CC=CC=C1C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42
|
|||
| InChI |
1S/C20H15NOS/c1-14-8-2-3-9-15(14)20(22)21-16-10-4-6-12-18(16)23-19-13-7-5-11-17(19)21/h2-13H,1H3
|
|||
| InChIKey |
PYIIIOAOKBCILO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| WikiPathways | Irinotecan Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.